MyAverix Finance
SHG · Healthcare
Shanghai Shen Lian Biomedical Corp (688098)
Biotechnology
Shanghai Shen Lian Biomedical Corp (688098) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $3.53B, P/E ratio is 18.00, net margin is -6.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688098
Shanghai Shen Lian Biomedical Corp (688098) — FAQ
What is Shanghai Shen Lian Biomedical Corp's market cap?
Shanghai Shen Lian Biomedical Corp (688098) has a reported market cap of $3.53B (data as of 2026-03-29).
What is 688098's P/E ratio?
The price-to-earnings (P/E) ratio for Shanghai Shen Lian Biomedical Corp (688098) is 18.00 (data as of 2026-03-29).
Does Shanghai Shen Lian Biomedical Corp pay a dividend?
Dividend yield is not available in the current snapshot for Shanghai Shen Lian Biomedical Corp (688098). Check the MyAverix Finance app for the latest dividend data.
What sector is Shanghai Shen Lian Biomedical Corp in?
Shanghai Shen Lian Biomedical Corp (688098) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688098 listed on?
688098 is listed on SHG.
What is Shanghai Shen Lian Biomedical Corp's net margin?
Shanghai Shen Lian Biomedical Corp (688098) reports a net margin of -6.6% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.